An unusual association between focal segmental sclerosis and lupus nephritis: a distinct concept from lupus podocytopathy?
Tóm tắt
Lupus nephritis (LN) is usually associated with immune deposition in the glomerular capillary wall. On the other hand, focal segmental glomerulosclerosis (FSGS) is not typically associated with immune deposition, and its pathogenesis includes podocyte damage and loss. The definition of lupus podocytopathy (LP) excludes patients with electron-dense glomerular basement membrane deposits. Here, we report the case of an LN patient with nephrotic proteinuria. Renal pathology demonstrated focal endocapillary hypercellularity superimposed on foam cells. Immunofluorescence revealed diffuse global subepithelial immune deposits, and electron microscopy showed electron-dense glomerular basement membrane deposits and diffuse foot process effacement. Treatment with steroid and cyclosporine improved her proteinuria. Post-treatment renal re-biopsy revealed focal segmental sclerotic lesions closely resembling FSGS. These results indicate that the pathogenesis of this case may involve an FSGS-like condition or podocytopathic change. It is possible that careful examination would reveal podocytopathic changes other than LP in patients previously diagnosed as LN class III + V. Further investigations are needed to understand FSGS-like pathological changes accompanied with capillary immune deposits in LN.
Tài liệu tham khảo
Tan EM. Pathophysiology of antinuclear antibodies in systemic lupus erythematosus and related diseases. Adv Dent Res. 1996;10:44–6.
Baldwin DS, Gluck ML, Lowenstein J, et al. Lupus nephritis: clinical course of related to morphologic forms and their transitions. Am J Med. 1977;62:12–30.
Hahn BH, McMahon MA, Wilkinson WD, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res. 2012;64:797–808.
Barisoni L, Schnaper HW, Kopp JB. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol. 2007;2:529–42.
Kraft SW, Schwartz MM, Korbet SM, Lewis EJ. Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am Soc Nephrol. 2005;16:175–9.
Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int. 2007;71:1205–14.
Thomas DB, Franceschini N, Hogan SL, et al. Clinical and pathologic characteristics of focal segmental glomerulo-sclerosis pathologic variants. Kidney Int. 2006;69:920–6.
Banfi G, Moriggi M, Sabadini E, Fell-in G, D’Amico G, Ponticelli C. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults: a collaborative retrospective study. Clin Nephrol. 1991;36:53–9.
Faul C, Donnelly M, Merscher-Gomez S, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med. 2008;14:931–8.
D’Agati VD, Fogo AB, Bruijin JA, Jannette JC. Pathological proposal of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004;43:368–82.
Huong D, Papo T, Beaufils H, et al. Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center. Medicine. 1999;78:148–66.
Hertig A, Droz D, Leasavre P, Grunfeld JP. SLE and idiopathic nephrotic syndrome: coincidence or not? Am J Kidney Dis. 2002;40:1179–84.